H.Y. Guo, Y. Yu / Chinese Chemical Letters 21 (2010) 1435–1438
1437
Table 2
Preparation of 4 in ionic liquid [bmim]BF4.
Entry
Ar
Product
Time (min)
Yielda (%)
1
2
C6H5–
4a
4b
4c
4d
4e
4f
30
30
40
30
40
45
30
30
30
30
30
30
88
90
77
92
82
79
91
92
76
89
91
85
4-Cl–C6H4–
3
4-MeO–C6H4–
4-F–C6H4–
4
5
4-OH–C6H4–
4-CH3–C6H4–
4-NO2–C6H4–
3-Br–C6H4–
4-OH–3-OCH3–C6H3–
2-Cl–C6H4–
6
7
4g
4h
4i
8
9
10
11
12
4j
2,4-Cl2–C6H3–
2-OH–C6H4–
4k
4l
a
Isolated yield.
withdrawing groups have higher reactivity (higher yields and shorter reaction time) than those bearing electron-
donating groups. So, it is concluded that the electronic nature of the substituents on aldehydes has some effect on this
reaction. It seems that the electron-withdrawing groups in aldehydes enhanced the electropositive property of b–C in
the intermediates yielded from the Knoevenagel condensation of aldehydes 1 with barbituric acid 3, which facilitated
the nucleophilic attack thereafter.
In summary, a series of 7-aryl-11,12-dihydrobenzo[h]pyrimido-[4,5-b]quinoline-8,10(7H,9H)-diones were
synthesized in ionic liquid [bmim]BF4. The procedure offers several advantages including high yields, operational
simplicity, cleaner reactions, minimal environmental impact, and provides a useful and attractive protocol for the
synthesis of these compounds.
Acknowledgment
This work was financially supported by the Research Foundation of Zhejiang Provincial Education Department
(No. 20060811).
References
[1] T. Kimachi, F. Yoneda, T. Sasaki, J. Heterocycl. Chem. 29 (1992) 763.
[2] D. Dorjsuren, A. Burnette, G.N. Gray, X. Chen, W. Zhu, P.E. Roberts, et al. Antiviral Res. 69 (2006) 9.
[3] A. Bond, Z. Reichert, J.T. Stivers, Mol. Pharmacol. 69 (2006) 547.
[4] T.R. Kau, F. Schroeder, S. Ramaswamy, C.L. Wojciechowski, J.J. Zhao, T.M. Roberts, et al. Cancer Cell 4 (2003) 463.
[5] A. Carta, M. Loriga, G. Paglietti, M. Ferrone, M. Fermeglia, S. Pricl, et al. Bioorg. Med. Chem. 15 (2007) 1914.
[6] A.D. Yapi, M. Mustofa, A. Valentin, O. Chavignon, J.C. Teulade, M. Mallie, et al. Chem. Pharm. Bull. 48 (2000) 1886.
[7] A. Shaabani, A. Rahmati, E. Farhangi, Tetrahedron Lett. 48 (2007) 7291.
[8] L.F. Tietze, A. Modi, Med. Res. Rev. 20 (2000) 304.
[9] I. Ugi, A. Domling, B. Werner, J. Heterocycl. Chem. 37 (2000) 647.
[10] T. Welten, Chem. Rev. 99 (1999) 2071.
[11] P. Wassercheid, W. Keim, Angew. Chem. Int. Ed. 39 (2000) 3772.
[12] R. Sheldon, Chem. Commun. (2001) 2399.
[13] J. Ranke, S. Stolte, R. Stormann, J. Arning, B. Jastorff, Chem. Rev. 107 (2007) 2183.
[14] J. Dupont, R.F. de Souza, P.A.Z. Suarez, Chem. Rev. 102 (2002) 3667.
[15] J. Khurana, D. Magoo, Tetrahedron Lett. 50 (2009) 4777.
[16] A typical procedure for the preparation of 4aÀ4l: Aldehyde (1, 2 mmol), 1-naphthylamine (2, 2 mmol), barbituric acid (3, 2 mmol) were added
to a 20 mL round bottom flask containing 2 mL [bmim]BF4. The mixture was then stirred at 90 8C for appropriate time (monitored by TLC).
After completion of the reaction, the reaction mixture was added with 5 mL water. The precipitate was collected by suction and purified by
recrystallization from EtOH to give products 4. The filtrate was concentrated under reduced pressure and dried at 100 8C to recover the ionic
liquid for subsequent use. Some selected data: 4c: mp >300 8C; 1H NMR (DMSO-d6, 500 MHz,): d 3.44 (s, 3H, OCH3); 5.13 (s, 1H, CH); 6.75–
7.95 (m, 10H, Ar–H); 9.09 (s, 1H, NH); 10.03 (s, 1H, NH); 10.69 (s, 1H, NH); IR (KBr, cmÀ1): vmax 3267, 3076, 2834, 1715, 1608, 1550, 1509,
1461, 1399, 1252, 1176, 1108, 1031, 810; MS (EI, 70 eV) (m/z, %): 371 (M+, 9.0), 368 (41.7), 369 (100), 264 (33.5), 207 (21.4); Anal. Calcd.